BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pfizer Inc. (PFE) Caves and Pulls Heartland Institute Support


12/20/2012 7:32:47 AM

After months of pressure and criticism, Pfizer (PFE) has quietly withdrawn its support from the Heartland Institute, a highly controversial group that downplays global warming and believes anti-smoking campaigns are based on junk science. Negative publicity over contributions has already prompted Bayer, Amgen, Eli Lilly and GlaxoSmithKline to disassociate themselves from the non-profit. The move come several months after a few dozen socially-minded investors and related activists – including Interfaith Center on Corporate Responsibility, Walden Asset Management, Unitarian Universalist Association and AFSCME – wrote the Pfizer board to force a change and requested a comprehensive review to justify its financial support. “The decision was made this month as part of our year end review,” a Pfizer spokeswoman writes us. “The main reason was budgetary constraints. But, in addition, Heartland’s primary focus will no longer be on pharmaceutical policy issues.” There was no formal announcement of the decision, she adds. In 2010, the drugmaker contributed $130,000, according to a Heartland document and $65,000 last year. Meanwhile, Pfizer signaled plans to contribute another $45,000 this year and future donations for 2013 and beyond, according to Forecast the Facts, an advocacy group that has been pushing companies to cut their ties.

Read at Pharmalot

Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES